Akso Health Group (AHG)
0.77
-0.07
(-8.34%)
USD |
NASDAQ |
Apr 24, 16:00
0.7855
+0.02
(+2.01%)
After-Hours: 20:00
Akso Health Group Total Liabilities (Quarterly): 11.55M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 11.55M |
| September 30, 2023 | 11.55M |
| March 31, 2023 | 11.62M |
| September 30, 2022 | 10.98M |
| September 30, 2022 | 10.98M |
| March 31, 2022 | 50.52M |
| September 30, 2021 | 12.97M |
| March 31, 2021 | 14.41M |
| September 30, 2020 | 33.13M |
| September 30, 2019 | 32.94M |
| Date | Value |
|---|---|
| June 30, 2019 | 32.23M |
| March 31, 2019 | 46.75M |
| December 31, 2018 | 17.01M |
| September 30, 2018 | 22.03M |
| June 30, 2018 | 25.26M |
| March 31, 2018 | 23.85M |
| December 31, 2017 | 21.35M |
| September 30, 2017 | 11.07M |
| June 30, 2017 | 7.124M |
| March 31, 2017 | 4.878M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.98M
Minimum
Sep 2022
50.52M
Maximum
Mar 2022
21.17M
Average
12.97M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Universe Pharmaceuticals Inc | 13.75M |
| Sinovac Biotech Ltd | 1.488B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 240.18M |
| I-MAB | 146.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.88M |
| Shareholders Equity (Quarterly) | 5.223M |
| Debt to Equity Ratio | 0.067 |
| Current Ratio | 1.462 |
| Net Debt Paydown Yield | -0.49% |